Has Wajid Choudhry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $410 in general payments to Wajid Choudhry, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wajid Choudhry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wajid Choudhry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wajid Choudhry, MD

Nephrology · Rochester, NYNPI 1235211475

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $299 of the $410 with a category attached, or 73.0%. 8 manufacturers reported payments, led by Calliditas Therapeutics US Inc. at 27.7% of the total. Reporting peaked in 2023 at $139 and has fallen 78.2% since, to $30 in 2025. That places this record below the midpoint for nephrology clinicians in NY, where the typical reported total is $564.

$410in general payments, 2019–2025

Across 27 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Calliditas Therapeutics US Inc.$114
Otsuka America Pharmaceutical, Inc.$91
Travere Therapeutics, Inc.$66
Ardelyx, Inc.$55
Pfizer$29
Baxter Healthcare$22
plus $33 from 2 others

What the payments were for

Food & beverage$29973%
Education$11027%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Calliditas Therapeutics US Inc.	1	$114
Otsuka America Pharmaceutical, Inc.	2	$91
Travere Therapeutics, Inc.	17	$66
Ardelyx, Inc.	2	$55
Pfizer	2	$29
Baxter Healthcare	1	$22
Amgen	1	$19
Fresenius USA Marketing, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TARPEYO$114

How this compares

$410 in reported general payments places this provider in the 40th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York →

Medicare billing

Part B allowed, 2024

$3,943

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ProsolParenteral Amino Acid 20% No.1	20	$4,222
ClinolipidFat Emulsion/Olive/Soy/Phospho	12	$3,069
Chlorthalidone	11	$298
Hydralazine Hcl	12	$117
Amlodipine Besylate	18	$82
Carvedilol	13	$74
Furosemide	11	$40

Paid to pharmacies, not to this prescriber.

Other nephrology in Rochester

Daniel GrayRochester$114K
Leslie WongRochester$48K
David BushinskyRochester$44K
James SloandRochester$33K
Payam ShakouriPoughkeepsie$930K
Gerald AppelNew York$842K
Richard ChanNew York$514K
Bruce SpinowitzBronx$465K
Steven CocaNew York$445K
Joseph RoglieriTroy$425K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →